Advertisement
Canada markets close in 1 hour 38 minutes
  • S&P/TSX

    22,295.38
    +52.04 (+0.23%)
     
  • S&P 500

    5,300.55
    +53.87 (+1.03%)
     
  • DOW

    39,825.89
    +267.78 (+0.68%)
     
  • CAD/USD

    0.7351
    +0.0025 (+0.35%)
     
  • CRUDE OIL

    78.69
    +0.67 (+0.86%)
     
  • Bitcoin CAD

    88,800.33
    +5,328.76 (+6.38%)
     
  • CMC Crypto 200

    1,373.02
    +105.08 (+8.29%)
     
  • GOLD FUTURES

    2,391.90
    +32.00 (+1.36%)
     
  • RUSSELL 2000

    2,105.52
    +19.83 (+0.95%)
     
  • 10-Yr Bond

    4.3480
    -0.0970 (-2.18%)
     
  • NASDAQ

    16,727.90
    +216.72 (+1.31%)
     
  • VOLATILITY

    12.66
    -0.76 (-5.66%)
     
  • FTSE

    8,445.80
    +17.67 (+0.21%)
     
  • NIKKEI 225

    38,385.73
    +29.67 (+0.08%)
     
  • CAD/EUR

    0.6758
    -0.0011 (-0.16%)
     

INOVIO to Participate in Upcoming Investor Conferences in May

PLYMOUTH MEETING, Pa., April 29, 2024 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that management will participate in the following investor conferences during the month of May:

(PRNewsfoto/INOVIO Pharmaceuticals, Inc.)
(PRNewsfoto/INOVIO Pharmaceuticals, Inc.)

The Citizens JMP Life Sciences Conference
Date: Tuesday, May 14, 2024
Time: 11:30 AM ET
Presenter: Dr. Jacqueline Shea, President & CEO
Format: Fireside Chat

RBC Capital Markets 2024 Global Healthcare Conference
Date: Wednesday, May 15, 2024
Time: 10:00 AM ET
Presenter: Dr. Jacqueline Shea, President & CEO
Format: Fireside Chat

ADVERTISEMENT

H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
Date: Monday, May 20, 2024
Time: 12:30 PM ET
Presenter: Dr. Jacqueline Shea, President & CEO
Format: Fireside Chat

During the conferences, Dr. Shea and members of INOVIO's management team will conduct one-on-one meetings with registered investors.

Webcasts of the fireside chats will be available on the INOVIO Investor Relations Events page at https://ir.inovio.com/events-and-presentations/default.aspx. Replays of the webcasts will be available for 90 days after the date of the presentation.

About INOVIO
INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com.

Contacts
Media: Jennie Willson (267) 429-8567 jennie.willson@inovio.com
Investors: Thomas Hong (267) 440-4298 thomas.hong@inovio.com

 

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/inovio-to-participate-in-upcoming-investor-conferences-in-may-302129665.html

SOURCE INOVIO Pharmaceuticals, Inc.